NCT02077998View on ClinicalTrials.gov

Oxaliplatin in Treating Patients With Metastatic Breast Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2015

Conditions
Stage IV Breast Cancer
Interventions
RADIATION

carbon C 14 oxaliplatin

Given IV

DRUG

oxaliplatin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

95817

UC Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Davis

OTHER

NCT02077998 - Oxaliplatin in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter